224 related articles for article (PubMed ID: 19483189)
1. Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines.
Sloan KA; Marquez HA; Li J; Cao Y; Hinds A; O'Hara CJ; Kathuria S; Ramirez MI; Williams MC; Kathuria H
Carcinogenesis; 2009 Aug; 30(8):1433-42. PubMed ID: 19483189
[TBL] [Abstract][Full Text] [Related]
2. Transcription of the caveolin-1 gene is differentially regulated in lung type I epithelial and endothelial cell lines. A role for ETS proteins in epithelial cell expression.
Kathuria H; Cao YX; Ramirez MI; Williams MC
J Biol Chem; 2004 Jul; 279(29):30028-36. PubMed ID: 15138262
[TBL] [Abstract][Full Text] [Related]
3. ERM is expressed by alveolar epithelial cells in adult mouse lung and regulates caveolin-1 transcription in mouse lung epithelial cell lines.
Kathuria H; Cao Y; Hinds A; Ramirez MI; Williams MC
J Cell Biochem; 2007 Sep; 102(1):13-27. PubMed ID: 17390339
[TBL] [Abstract][Full Text] [Related]
4. Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells.
Martin ME; Yang XY; Folk WR
Mol Cell Biol; 1992 May; 12(5):2213-21. PubMed ID: 1569949
[TBL] [Abstract][Full Text] [Related]
5. Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion.
Hiroumi H; Dosaka-Akita H; Yoshida K; Shindoh M; Ohbuchi T; Fujinaga K; Nishimura M
Int J Cancer; 2001 Sep; 93(6):786-91. PubMed ID: 11519038
[TBL] [Abstract][Full Text] [Related]
6. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
7. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
[TBL] [Abstract][Full Text] [Related]
8. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 is essential for metformin inhibitory effect on IGF1 action in non-small-cell lung cancer cells.
Salani B; Maffioli S; Hamoudane M; Parodi A; Ravera S; Passalacqua M; Alama A; Nhiri M; Cordera R; Maggi D
FASEB J; 2012 Feb; 26(2):788-98. PubMed ID: 22038047
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Lynch CC; Crawford HC; Matrisian LM; McDonnell S
Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
[TBL] [Abstract][Full Text] [Related]
12. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
[TBL] [Abstract][Full Text] [Related]
13. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
14. Decreased TIP30 expression promotes tumor metastasis in lung cancer.
Tong X; Li K; Luo Z; Lu B; Liu X; Wang T; Pang M; Liang B; Tan M; Wu M; Zhao J; Guo Y
Am J Pathol; 2009 May; 174(5):1931-9. PubMed ID: 19349353
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of FURIN by prostaglandin-endoperoxide synthase 2 in lung epithelial NCI-H292 cells.
Brant KA; Leikauf GD
Mol Carcinog; 2014 Mar; 53(3):192-200. PubMed ID: 23065687
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer.
Zhu X; Guo Y; Li X; Ding Y; Chen L
J Thorac Oncol; 2010 Aug; 5(8):1159-66. PubMed ID: 20661085
[TBL] [Abstract][Full Text] [Related]
17. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene.
Kopp JL; Wilder PJ; Desler M; Kim JH; Hou J; Nowling T; Rizzino A
J Biol Chem; 2004 May; 279(19):19407-20. PubMed ID: 14976186
[TBL] [Abstract][Full Text] [Related]
18. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone.
Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B
Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939
[TBL] [Abstract][Full Text] [Related]
19. ETS2 is involved in protein kinase C-activated expression of granulocyte-macrophage colony-stimulating factor in human non-small lung carcinoma cell line, A549.
Lu Z; Kim KA; Suico MA; Uto A; Seki Y; Shuto T; Isohama Y; Miyata T; Kai H
Biochem Biophys Res Commun; 2003 Mar; 303(1):190-5. PubMed ID: 12646185
[TBL] [Abstract][Full Text] [Related]
20. Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer.
Suzuki C; Takahashi K; Hayama S; Ishikawa N; Kato T; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
Mol Cancer Ther; 2007 Feb; 6(2):542-51. PubMed ID: 17308053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
